Embedded Files
Pharmaceutical company focused on Medical Dermatology
Pharmaceutical company focused on Medical Dermatology
We develop and commercialize new chemical tools for biological assay development in drug discovery
We develop and commercialize new chemical tools for biological assay development in drug discovery
GSK is a global biopharmaceutical company driven by responsible innovation, with the purpose of bringing together science, technology, and talent to get ahead of disease. Our goal is to have a positive impact on the health of 2.5 billion people by the end of 2030.
GSK is a global biopharmaceutical company driven by responsible innovation, with the purpose of bringing together science, technology, and talent to get ahead of disease. Our goal is to have a positive impact on the health of 2.5 billion people by the end of 2030.
R&D center in Spain located in Alcobendas (Madrid), where more than one hundred scientists work on the discovery of innovative medicines.
R&D center in Spain located in Alcobendas (Madrid), where more than one hundred scientists work on the discovery of innovative medicines.
The mission of this Research Center, which carries out its work in the field of Medicinal Chemistry, is to design and synthesize new molecules with potential biological interest. Nearly 40 researchers conduct their projects here across several areas, including Neuroscience (Psychiatry and Neurology), Oncology, Immunology, and Infectious Diseases (tuberculosis).
The mission of this Research Center, which carries out its work in the field of Medicinal Chemistry, is to design and synthesize new molecules with potential biological interest. Nearly 40 researchers conduct their projects here across several areas, including Neuroscience (Psychiatry and Neurology), Oncology, Immunology, and Infectious Diseases (tuberculosis).
Our passion for chemistry has made us a benchmark over the years, positioning GalChimia as a European leader in chemical synthesis. We are a family-owned company that works in close collaboration with our clients, building strong relationships based on trust, reliability, and communication.
Our passion for chemistry has made us a benchmark over the years, positioning GalChimia as a European leader in chemical synthesis. We are a family-owned company that works in close collaboration with our clients, building strong relationships based on trust, reliability, and communication.
In the drug discovery area, our research team works to develop potential medicines across four distinct therapeutic areas: allergic diseases, gastrointestinal disorders, ophthalmology, bone immunomodulation, and pain. To support this work, we have molecular biology, chemical synthesis, automated chemistry, and analytical laboratories, as well as facilities for the development of in vivo animal models.
In the drug discovery area, our research team works to develop potential medicines across four distinct therapeutic areas: allergic diseases, gastrointestinal disorders, ophthalmology, bone immunomodulation, and pain. To support this work, we have molecular biology, chemical synthesis, automated chemistry, and analytical laboratories, as well as facilities for the development of in vivo animal models.
Our activity consists in the development and application of computational methods for the evaluation of physicochemical, biological and/or (eco)toxicological properties of chemicals, either of natural origin or synthesized. Our computer tools allow us to work in a “virtual” environment, which has advantages over traditional laboratory tests.
Our activity consists in the development and application of computational methods for the evaluation of physicochemical, biological and/or (eco)toxicological properties of chemicals, either of natural origin or synthesized. Our computer tools allow us to work in a “virtual” environment, which has advantages over traditional laboratory tests.
MolDrug AI Systems works in the field of computational chemistry, molecular modeling, and in general in technologies for computational optimization of chemical compound properties
MolDrug AI Systems works in the field of computational chemistry, molecular modeling, and in general in technologies for computational optimization of chemical compound properties
Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment refractory advanced cancer patients.
Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment refractory advanced cancer patients.
Page updated
Google Sites
Report abuse